News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Daily News Women Less Likely Than Men to Experience SCD During Sports Michael O'Riordan December 21, 2021
News Features Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign L.A. McKeown December 20, 2021
News Features As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years Caitlin E. Cox December 16, 2021
News Features World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard Shelley Wood December 13, 2021
News Daily News The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI Caitlin E. Cox December 09, 2021
News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
News Daily News Cardiopulmonary Tests Urged for Lasting Fatigue, Dyspnea After COVID-19 Todd Neale December 02, 2021
News Daily News Rapid ESC hs-cTn Algorithms Best 3-Hour Protocol for MI Rule-out: Meta-analysis Yael L. Maxwell November 23, 2021
News Daily News US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access L.A. McKeown November 23, 2021
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Daily News ESC Releases Guidance on How to Address CVD in COVID-19 Era Yael L. Maxwell November 17, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021